Safety and Immunogenicity Study of V710 Lyophilized Formulation (V710-004)
Clinical trial NCT00822757 · COMPLETED
Trial details
- NCT number
- NCT00822757
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-08-01
- Primary completion
- 2007-10-01
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.